Considerations surrounding the use of the FLIPI2 and PRIMA-PI scoring systems for risk assessment of patients with high-risk follicular lymphoma, and making decisions for treatment initiation versus a watch-and-wait approach.
For more resources and information regarding anticancer targeted therapies: targetedonc.com/
27 июл 2024